Results 121 to 130 of about 69,031,262 (351)

Was COVID‐19 Associated With Worsening Inequities in Stroke Treatment and Outcomes?

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background COVID‐19 stressed hospitals and may have disproportionately affected the stroke outcomes and treatment of Black and Hispanic individuals. Methods and Results This retrospective study used 100% Medicare Provider Analysis and Review file data ...
Laurent G. Glance, Curtis G. Benesch, Karen E. Joynt Maddox, Matthew T. Bender, Jingjing Shang, Patricia W. Stone, Stewart J. Lustik, Jacob W. Nadler, Christopher Galton, Andrew W. Dick   +9 more
doaj   +1 more source

Lopinavir/ritonavir: Repurposing an old drug for HIV infection in COVID-19 treatment

Biomedical Journal, 2020
Currently, there is no specific antiviral treatment for COVID-19. However, drugs previously developed to treat other viral infections are being tested to verify if they might also be effective against SARS-CoV-2, the virus that causes COVID-19.
Paola Magro, I. Zanella, Marta Pescarolo, F. Castelli, E. Quiros-Roldan   +4 more
semanticscholar   +1 more source

Determinants of undergraduate bioscience engagement: Validating attendance barriers and classroom spatial behaviour across institutions

FEBS Open Bio, EarlyView.
Student engagement extends beyond simple attendance. Across 891 bioscience students from three universities, attendance behaviour was associated mainly with structural influences, whereas classroom spatial behaviour reflected affective and sensory factors.
Nigel Page, Rachel J. Hunt, Lauren J. Albee, Daniel Berwick, Alison Snape   +4 more
wiley   +1 more source

Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action

Lancet Global Health, 2020
Inclusion of pregnant women in COVID-19 clinical trials would allow evaluation of effective therapies that might improve maternal health, pregnancy, and birth outcomes, and avoid the delay of developing treatment recommendations for pregnant women.
M. Taylor, L. Kobeissi, C. Kim, A. Amin, A. Thorson, Nita Bellare, V. Brizuela, M. Bonet, E. Kara, S. Thwin, Hamsadvani Kuganantham, Moazzam Ali, O. Oladapo, Nathalie J. Broutet   +13 more
semanticscholar   +1 more source

Fluorination: A strategy to tune the interactions of molecules and nanoscale systems with biological matter

FEBS Open Bio, EarlyView.
This minireview explores fluorination as a key strategy to optimize therapeutic molecules and nanocarriers. By incorporating different fluorinated motifs—from single atoms to linear and branched chains—drug delivery, cellular uptake, and colloidal stability can be improved and fine‐tuned.
Martina Beccalli, Beatrice Lucia Bona, Francesca Baldelli Bombelli   +2 more
wiley   +1 more source

A Review of Extracellular Vesicles in COVID‐19 Diagnosis, Treatment, and Prevention

Advanced Science, 2023
The 2019 novel coronavirus disease (COVID‐19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is ongoing, and has necessitated scientific efforts in disease diagnosis, treatment, and prevention.
Peng Su, Yuchen Wu, Feng Xie, Qinghui Zheng, Long Chen, Zhuang Liu, Xuli Meng, Fangfang Zhou, Long Zhang   +8 more
doaj   +1 more source

Insights from nanotechnology in COVID-19 treatment

Nano Today, 2020
Graphical ...
Zhongmin Tang, Xing-Cai Zhang, Yiqing Shu, M. Guo, Han Zhang, Wei Tao   +5 more
semanticscholar   +1 more source

Five‐Year Outcomes of Laparoscopic Sphincter‐Preserving Surgery for Rectal Cancer: A Prospective Study in Elderly Vietnamese Patients

Aging and Cancer, EarlyView.
This prospective study demonstrates that laparoscopic sphincter‐preserving surgery is feasible for elderly patients. While overall survival reaches 70% at 5 years, advanced T‐stage and the omission of neoadjuvant therapy significantly drive recurrence, highlighting the need for personalized geriatric protocols despite logistical challenges.
Huu Duc Ho, Quang Le, Ngoc Thach Tran, Van Viet Ung, Loc Vu   +4 more
wiley   +1 more source

Treatment of COVID-19

The journal of Tepecik Education and Research Hospital, 2020
Covid 19; 2019 yılı aralık ayında çin’in wuhan bölgesinden başlayarak bugün tüm dünyayı etkisi altına alarak pandemi boyutuna ulaşmıştır. Asemptomatik hastalıktan ; ağır pnomoni klinğine kadar ilerleyen geniş bir klinik yelpazeye sahiptir. Tedavi protokolleri halen rehber önerileri ve klinik çalışmalar ile sınırlıdır ve henüz kullanıma girmiş spesifik ...
Sabri Atalay, Gürsel Ersan
openaire   +4 more sources

Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment

Clinical Immunology, 2020
Approximately 15% of patients with coronavirus disease 2019 (COVID-19) experience severe disease, and 5% progress to critical stage that can result in rapid death. No vaccines or antiviral treatments have yet proven effective against COVID-19.
S. Yeleswaram, Paul A. Smith, T. Burn, M. Covington, Ashish P. Juvekar, Yan-Long Li, Peg Squier, P. Langmuir   +7 more
semanticscholar   +1 more source